Title | Type | SJR | H index | Total Docs. (1999) | Total Docs. (3years) | Total Refs. (1999) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (1999) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Pharmacological Reviews | journal | 7.884 Q1 | 254 | 19 | 57 | 8938 | 935 | 57 | 15.39 | 470.42 | |
2 | Pharmacology and Toxicology, Supplement | journal | 0.138 Q3 | 7 | 1 | 40 | 389 | 16 | 40 | 0.40 | 389.00 | |
3 | Progress in Medicinal Chemistry | journal | 0.657 Q1 | 38 | 7 | 20 | 1411 | 37 | 12 | 1.25 | 201.57 | |
4 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.271 Q1 | 70 | 31 | 22 | 5954 | 143 | 22 | 8.20 | 192.06 | |
5 | Advances in Pharmacology | journal | 1.389 Q1 | 86 | 17 | 378 | 3069 | 985 | 368 | 2.04 | 180.53 | |
6 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.380 Q1 | 82 | 12 | 30 | 1994 | 157 | 30 | 5.42 | 166.17 | |
7 | Pharmacology and Therapeutics | journal | 2.964 Q1 | 233 | 73 | 148 | 11003 | 1043 | 148 | 7.68 | 150.73 | |
8 | Expert Opinion on Therapeutic Targets | journal | 0.123 Q4 | 106 | 40 | 118 | 4160 | 9 | 116 | 0.08 | 104.00 | |
9 | Cellular and Molecular Life Sciences | journal | 1.724 Q1 | 261 | 227 | 449 | 21816 | 1104 | 447 | 2.92 | 96.11 | |
10 | Food and Drug Law Journal | journal | 0.306 Q2 | 23 | 48 | 155 | 4007 | 59 | 155 | 0.45 | 83.48 | |
11 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.126 Q4 | 29 | 11 | 28 | 879 | 5 | 26 | 0.15 | 79.91 | |
12 | Medicinal Research Reviews | journal | 1.562 Q1 | 150 | 34 | 61 | 2700 | 243 | 61 | 2.68 | 79.41 | |
13 | Expert Opinion on Investigational Drugs | journal | 0.348 Q2 | 117 | 155 | 426 | 12075 | 435 | 418 | 1.06 | 77.90 | |
14 | Epitheorese Klinikes Farmakologias kai Farmakokinetikes | journal | 0.100 Q4 | 5 | 8 | 44 | 607 | 0 | 44 | 0.00 | 75.88 | |
15 | Clinical Pharmacokinetics | journal | 1.586 Q1 | 184 | 81 | 186 | 5697 | 1014 | 178 | 5.21 | 70.33 | |
16 | Drug Safety | journal | 0.795 Q1 | 140 | 92 | 208 | 6358 | 598 | 202 | 2.83 | 69.11 | |
17 | Expert Opinion on Emerging Drugs | journal | 0.264 Q3 | 54 | 20 | 43 | 1380 | 34 | 42 | 0.79 | 69.00 | |
18 | BioDrugs | journal | 0.226 Q3 | 79 | 79 | 272 | 5247 | 182 | 257 | 0.65 | 66.42 | |
19 | Investigational New Drugs | journal | 0.720 Q1 | 97 | 38 | 143 | 2490 | 301 | 142 | 2.01 | 65.53 | |
20 | Drug Resistance Updates | journal | 0.642 Q2 | 132 | 51 | 56 | 3305 | 109 | 48 | 1.95 | 64.80 | |
21 | EOS Rivista di Immunologia ed Immunofarmacologia | journal | 0.141 Q3 | 5 | 23 | 48 | 1457 | 4 | 46 | 0.11 | 63.35 | |
22 | Adverse Drug Reactions and Toxicological Reviews | journal | 0.197 Q3 | 25 | 15 | 51 | 919 | 35 | 40 | 0.79 | 61.27 | |
23 | Side Effects of Drugs Annual | book series | 0.101 Q4 | 9 | 51 | 102 | 3092 | 2 | 102 | 0.02 | 60.63 | |
24 | Current Opinion in Molecular Therapeutics | journal | 67 | 93 | 0 | 5163 | 0 | 0 | 0.00 | 55.52 | ||
25 | Expert Opinion on Pharmacotherapy | journal | 93 | 16 | 0 | 861 | 0 | 0 | 0.00 | 53.81 | ||
26 | Annual Report of Shionogi Research Laboratory | journal | 0.142 Q3 | 2 | 2 | 7 | 106 | 1 | 7 | 0.25 | 53.00 | |
27 | Drugs of Today | journal | 0.203 Q3 | 57 | 102 | 273 | 5395 | 128 | 272 | 0.40 | 52.89 | |
28 | Cytokines, Cellular and Molecular Therapy | journal | 0.670 Q1 | 28 | 26 | 56 | 1337 | 101 | 55 | 1.80 | 51.42 | |
29 | Apoptosis : an international journal on programmed cell death | journal | 0.700 Q1 | 128 | 48 | 130 | 2463 | 202 | 130 | 1.44 | 51.31 | |
30 | Antiviral Chemistry and Chemotherapy | journal | 0.497 Q2 | 59 | 32 | 176 | 1616 | 306 | 175 | 1.79 | 50.50 | |
31 | Neuropsychopharmacology | journal | 2.634 Q1 | 249 | 176 | 309 | 8662 | 1624 | 291 | 4.69 | 49.22 | |
32 | Experimental and Clinical Psychopharmacology | journal | 0.719 Q1 | 101 | 53 | 143 | 2565 | 240 | 143 | 1.43 | 48.40 | |
33 | Cardiovascular Drug Reviews | journal | 0.300 Q2 | 54 | 28 | 68 | 1342 | 52 | 68 | 0.96 | 47.93 | |
34 | Neuropharmacology | journal | 2.249 Q1 | 191 | 182 | 563 | 8527 | 2242 | 556 | 4.05 | 46.85 | |
35 | Drugs of the Future | journal | 0.209 Q3 | 46 | 100 | 1336 | 4625 | 350 | 1285 | 0.39 | 46.25 | |
36 | International Journal of Neuropsychopharmacology | journal | 0.324 Q2 | 125 | 40 | 26 | 1850 | 20 | 26 | 0.77 | 46.25 | |
37 | Trends in Pharmacological Sciences | journal | 4.514 Q1 | 244 | 102 | 304 | 4699 | 2317 | 233 | 8.20 | 46.07 | |
38 | Current Opinion in Drug Discovery and Development | journal | 1.523 Q1 | 85 | 68 | 15 | 3096 | 67 | 15 | 4.47 | 45.53 | |
39 | Antiviral Research | journal | 0.703 Q1 | 151 | 70 | 217 | 3183 | 441 | 216 | 1.98 | 45.47 | |
40 | Biomedicine and Pharmacotherapy | journal | 0.290 Q3 | 149 | 74 | 231 | 3319 | 170 | 201 | 0.79 | 44.85 | |
41 | Receptors and Channels | journal | 1.182 Q1 | 44 | 21 | 78 | 923 | 148 | 78 | 1.65 | 43.95 | |
42 | Toxicology and Applied Pharmacology | journal | 1.004 Q1 | 189 | 234 | 787 | 10010 | 2064 | 776 | 2.59 | 42.78 | |
43 | Adverse Drug Reaction Bulletin | journal | 0.158 Q3 | 8 | 6 | 19 | 256 | 8 | 19 | 0.58 | 42.67 | |
44 | IDrugs : the investigational drugs journal | journal | 0.237 Q3 | 39 | 183 | 58 | 7804 | 20 | 58 | 0.34 | 42.64 | |
45 | Addiction Biology | journal | 0.421 Q2 | 93 | 47 | 119 | 1993 | 128 | 117 | 1.14 | 42.40 | |
46 | Pharmacology Biochemistry and Behavior | journal | 0.861 Q1 | 148 | 298 | 1043 | 12568 | 1977 | 1040 | 1.86 | 42.17 | |
47 | Psychopharmacology | journal | 1.687 Q1 | 214 | 393 | 936 | 16557 | 3330 | 907 | 3.02 | 42.13 | |
48 | Expert Opinion on Therapeutic Patents | journal | 0.356 Q2 | 88 | 143 | 398 | 6018 | 323 | 394 | 1.02 | 42.08 | |
49 | Drug News and Perspectives | journal | 0.208 Q3 | 53 | 60 | 208 | 2509 | 93 | 200 | 0.45 | 41.82 | |
50 | Biochemical Pharmacology | journal | 1.178 Q1 | 220 | 394 | 1293 | 16303 | 3522 | 1223 | 2.67 | 41.38 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®